Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

MiNK Therapeutics, Inc. (INKT)

7.61
+0.02
+(0.26%)
At close: April 23 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
10,650.24
10,650.24
22,921.11
30,949.28
18,606.30
Operating Income
-10,650.24
-10,650.24
-22,921.11
-30,949.28
-18,606.30
Net Non Operating Interest Income Expense
172.57
172.57
463.26
253.32
-2,431.61
Other Income Expense
-307.13
-307.13
-0.01
2,704.74
-9,174.86
Pretax Income
-10,784.80
-10,784.80
-22,457.86
-27,991.21
-30,212.77
Net Income Common Stockholders
-10,784.80
-10,784.80
-22,457.86
-27,991.21
-30,212.77
Diluted NI Available to Com Stockholders
-10,784.80
-10,784.80
-22,457.86
-27,991.21
-30,212.77
Basic EPS
-2.86
-2.86
-6.54
-8.30
-11.60
Diluted EPS
-2.86
-2.86
-6.54
-8.30
-11.60
Basic Average Shares
3,773.33
3,773.33
3,435.99
3,367.29
2,602.55
Diluted Average Shares
3,773.33
3,773.33
3,435.99
3,367.29
2,602.55
Total Operating Income as Reported
-11,288.29
-11,288.29
-22,921.11
-30,949.28
-28,358.59
Total Expenses
10,650.24
10,650.24
22,921.11
30,949.28
18,606.30
Net Income from Continuing & Discontinued Operation
-10,784.80
-10,784.80
-22,457.86
-27,991.21
-30,212.77
Normalized Income
-10,146.76
-10,146.76
-22,457.86
-27,991.21
-20,815.99
Interest Income
172.57
172.57
463.26
253.32
--
Interest Expense
--
--
--
--
2,431.61
Net Interest Income
172.57
172.57
463.26
253.32
-2,431.61
EBIT
-10,650.24
-10,650.24
-22,921.11
-30,949.28
-18,606.30
EBITDA
-10,434.80
-10,434.80
-22,716.49
-30,827.53
-18,528.34
Reconciled Depreciation
215.44
215.44
204.62
121.75
77.96
Net Income from Continuing Operation Net Minority Interest
-10,784.80
-10,784.80
-22,457.86
-27,991.21
-30,212.77
Total Unusual Items Excluding Goodwill
-638.05
-638.05
--
--
-9,396.78
Total Unusual Items
-638.05
-638.05
--
--
-9,396.78
Normalized EBITDA
-9,796.76
-9,796.76
-22,716.49
-30,827.53
-9,131.56
12/31/2021 - 10/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AGEN Agenus Inc.
2.8500
-0.70%
 
PTIX Protagenic Therapeutics, Inc.
0.2273
+0.80%
 
TCRT Alaunos Therapeutics, Inc.
2.4600
+2.50%
 
PTCT PTC Therapeutics, Inc.
49.95
+3.65%
 
VYGR Voyager Therapeutics, Inc.
3.4900
+3.56%
 
MRKR Marker Therapeutics, Inc.
1.1700
-1.68%
 
IPSC Century Therapeutics, Inc.
0.5400
0.00%
 
AZTR Azitra, Inc.
0.2950
+3.87%
 
ASBPW Aspire Biopharma Holdings, Inc.
0.0600
+20.00%
 
SVRA Savara Inc.
3.2500
+0.93%